Hollings Renton, President and CEO at ONYX PHARMACEUTICALS INC (ONXX), sold 133,600 shares at $28.02 ($3.7M) on 2007-02-21, disclosed to the SEC on 2007-02-23.
Open-market sale of $3.7M ONXX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.88 | 7,000 | $195K | 5.2% |
| 2 | $27.99 | 11,000 | $308K | 8.2% |
| 3 | $28.00 | 10,000 | $280K | 7.5% |
| 4 | $28.00 | 61,195 | $1.7M | 45.7% |
| 5 | $28.00 | 4,000 | $112K | 3.0% |
| 6 | $28.02 | 9,000 |
| $252K |
| 6.7% |
| 7 | $28.02 | 12,000 | $336K | 9.0% |
| 8 | $28.02 | 3,000 | $84K | 2.2% |
| 9 | $28.53 | 16,405 | $468K | 12.5% |
| Total | $28.06 avg | 133,600 | $3.7M | 100% |
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |